We concluded that correlations between IFNβ1 and MX1 and survival in breast cancer patients exactly reflect relationships identified in vitro, with CAF-induced IFN activity correlating with chemoresistance and consequently poor survival, specifically within claudin-low cancers. Here, MX1 is linked to breast cancer.